10:35am ET
Health and Healthcare
Top Health Care Earnings Coming Next Week
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
Companies
/Healthcare
Biogen Inc
$218.50
▼ $3.00 (−1.35%) today
Markets closed · 10:52am ET
BIIB Coverage
Page 209:55am ET
Health and Healthcare
Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
7:10am ET
Health and Healthcare
Short Sellers Have Mixed Views on Major Biotechs
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
10:05am ET
Health and Healthcare
Top 6 Biopharma Gainers of the Past Week
Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains.
11:15am ET
Health and Healthcare
Anavex Soars on Biogen Agreement
Shares of Anavex Life Sciences soared on Wednesday following a material transfer agreement with Biogen.
Chris Lange 7:50am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
7:05am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Devon Energy, Gilead, Mondelez, Urban Outfitters and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Biogen, Broadcom, Devon Energy, Gilead Sciences, Mondelez and Urban Outfitters.
8:40am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
8:20am ET
Health and Healthcare
Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming
Investors are now focusing on fundamentals and near-term catalysts that could provide a tailwind for some of the biotech leaders.
8:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
10:40am ET
Health and Healthcare
Merrill Lynch Says the Time to Put Money Into Biotech Is Now
Though these four large cap biotech stocks are cheap relative to the S&P 500, history says they won’t stay that way.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Discovery Communications, Mosaic, Plains All American, Phillips 66, Rubicon Project and More
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Biogen, Discovery Communications, Mosaic, Plains All American, Phillips 66 and Rubicon Project.
9:25am ET
Health and Healthcare
RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there was little to no mention of drug pricing.
9:05am ET
Health and Healthcare
How Biogen and Ionis Won Big (and Can Win More) From Late Stage Trial
Shares of Biogen and, especially, Ionis Pharmaceuticals made handy gains early Monday morning following favorable interim results from a late-stage trial.
Chris Lange